13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Exome Sequencing Identifies Rare Variants in Multiple Genes in Atrioventricular Septal Defect

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          The genetic etiology of atrioventricular septal defect (AVSD) is unknown in 40% cases. Conventional sequencing and arrays have identified the etiology in only a minority of non-syndromic individuals with AVSD.

          Methods

          Whole exome sequencing was performed in 81 unrelated probands with AVSD to identify potentially causal variants in a comprehensive set of 112 genes with strong biological relevance to AVSD.

          Results

          A significant enrichment of rare and rare/damaging variants was identified in the gene set, compared with controls (odds ratio 1.52, 95% confidence interval 1.35–1.71, p = 4.8 x 10 -11). The enrichment was specific to AVSD probands compared with a non-AVSD cohort with tetralogy of Fallot (odds ratio 2.25, 95% confidence interval 1.84-2.76, p = 2.2 x 10 -16). Six genes ( NIPBL, CHD7, CEP152, BMPR1a, ZFPM2 and MDM4) were enriched for rare variants in AVSD compared to controls, including three syndrome-associated genes ( NIPBL, CHD7, CEP152). The findings were confirmed in a replication cohort of 81 AVSD probands.

          Conclusion

          Mutations in genes with strong biological relevance to AVSD, including syndrome-associated genes, can contribute to AVSD even in those with isolated heart disease. The identification of a gene set associated with AVSD will facilitate targeted genetic screening in this cohort.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          A map of human genome variation from population-scale sequencing.

          The 1000 Genomes Project aims to provide a deep characterization of human genome sequence variation as a foundation for investigating the relationship between genotype and phenotype. Here we present results of the pilot phase of the project, designed to develop and compare different strategies for genome-wide sequencing with high-throughput platforms. We undertook three projects: low-coverage whole-genome sequencing of 179 individuals from four populations; high-coverage sequencing of two mother-father-child trios; and exon-targeted sequencing of 697 individuals from seven populations. We describe the location, allele frequency and local haplotype structure of approximately 15 million single nucleotide polymorphisms, 1 million short insertions and deletions, and 20,000 structural variants, most of which were previously undescribed. We show that, because we have catalogued the vast majority of common variation, over 95% of the currently accessible variants found in any individual are present in this data set. On average, each person is found to carry approximately 250 to 300 loss-of-function variants in annotated genes and 50 to 100 variants previously implicated in inherited disorders. We demonstrate how these results can be used to inform association and functional studies. From the two trios, we directly estimate the rate of de novo germline base substitution mutations to be approximately 10(-8) per base pair per generation. We explore the data with regard to signatures of natural selection, and identify a marked reduction of genetic variation in the neighbourhood of genes, due to selection at linked sites. These methods and public data will support the next phase of human genetic research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium.

            We disrupted the FOG-2 gene in mice to define its requirement in vivo. FOG-2(-/-) embryos die at midgestation with a cardiac defect characterized by a thin ventricular myocardium, common atrioventricular canal, and the tetralogy of Fallot malformation. Remarkably, coronary vasculature is absent in FOG-2(-/-) hearts. Despite formation of an intact epicardial layer and expression of epicardium-specific genes, markers of cardiac vessel development (ICAM-2 and FLK-1) are not detected, indicative of failure to activate their expression and/or to initiate the epithelial to mesenchymal transformation of epicardial cells. Transgenic reexpression of FOG-2 in cardiomyocytes rescues the FOG-2(-/-) vascular phenotype, demonstrating that FOG-2 function in myocardium is required and sufficient for coronary vessel development. Our findings provide the molecular inroad into the induction of coronary vasculature by myocardium in the developing heart.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Impact of Prenatal Risk Factors on Congenital Heart Disease in the Current Era

              Background The healthcare burden related to congenital heart disease (CHD) is increasing with improving survival. We assessed changing trends in prenatal risk factors for CHD in the current era in a Canadian cohort. Methods and Results CHD patients <18 years old (n=2339) and controls without structural heart disease (n=199) were prospectively enrolled in an Ontario province‐wide biobank registry from 2008–2011. Family history, frequency of extra‐cardiac anomalies (ECAs), and antenatal risk factors were assessed. Temporal trends were analyzed and associations with CHD were measured using linear and logistic regression. Family history of CHD and frequency of major ECAs was higher in cases versus controls (P<0.001). Despite an increase in genetic testing in the recent era, only 9.5% of cases with CHD had a confirmed genetic diagnosis. Yield of genetic testing (ie, frequency of abnormal results) was higher in familial and syndromic cases. There was an increase in parental age at conception, maternal prepregnancy body mass index, maternal urinary tract infections, type 1 diabetes, and exposure to nonfertility medications during pregnancy from 1990–2011. Later year of birth, family history of CHD, presence of major ECAs, maternal smoking during pregnancy, and maternal medication exposure were associated with increased odds of CHD (P<0.05 for all). Advanced parental age was associated with increased odds of CHD caused by genetic abnormalities. Conclusions The increase in prenatal risk factors for CHD highlights the need for more rigorous ascertainment of genetic and environmental factors including gene‐environment interactions that contribute to CHD.
                Bookmark

                Author and article information

                Journal
                9815831
                22061
                Genet Med
                Genet. Med.
                Genetics in medicine : official journal of the American College of Medical Genetics
                1098-3600
                1530-0366
                24 May 2018
                21 May 2015
                February 2016
                05 June 2018
                : 18
                : 2
                : 189-198
                Affiliations
                [1 ]Division of Cardiology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1X8, Canada
                [2 ]Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK
                [3 ]Department of Pathology, King Abdulaziz Medical City, Riyadh, 11426, Saudi Arabia
                [4 ]Heart Center, Academic Medical Center, Amsterdam, The Netherlands
                [5 ]Division of Cardiology, Department of Medicine, London Health Sciences Centre, London, Ontario, N6A 5A5, Canada
                [6 ]Department of Paediatrics, London Health Sciences Centre, London, Ontario, N6A 5W9, Canada
                [7 ]Department of Pediatrics, Hamilton Health Sciences Centre, Hamilton, Ontario, L8N 3Z5, Canada
                [8 ]Division of Cardiology, Department of Medicine, Hamilton Health Sciences Centre, Hamilton, Ontario, L8N 3Z5, Canada
                [9 ]Division of Cardiology, Department of Pediatrics, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, K1H 8L1, Canada
                [10 ]Department of Pediatrics, Kingston General Hospital, Kingston, Ontario, K7L 2V7, Canada
                [11 ]Centre for Human Genetics, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
                [12 ]Radcliffe Department of Medicine & Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
                [13 ]Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02459, USA
                [14 ]Division of Genetics, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1X8, Canada
                Author notes
                [** ]Correspondence to: Seema Mital, Professor of Pediatrics, University of Toronto, Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada, Tel: 416-813-7418, Fax: 416-813-5857, seema.mital@ 123456sickkids.ca ; Matthew E. Hurles, The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA UK, Tel: +44 (0) 1223 495377, Fax: +44 (0) 1223 494919, meh@ 123456sanger.ac.uk
                Article
                EMS63304
                10.1038/gim.2015.60
                5988035
                25996639
                770ee137-82f8-4e7b-b2de-d13e8927c649

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Genetics
                whole exome sequencing,targeted sequencing,atrioventricular septal defect,endocardial cushion defect,atrioventricular canal defect,congenital heart disease,cornelia de lange syndrome,charge syndrome

                Comments

                Comment on this article